3D Tissue Models
Mastering Medicinal Chemistry
The Moscone North Convention Cente
747 Howard Street
San Francisco-94103, CA

Molecular diagnostics


Molecular Diagnostics
Mastering Medicinal Chemistry
Pathway Analysis
Stem Cells Congress
R&D Risk Mitigation
Clinical Trials Asia
Preclinical Development
Translational Medicine
Cytokine-Based Therapeutics
Cancer Molecular Markers
Trends in Drug Safety

Schedule of Presentations:

Tuesday, March 25, 2008
07:00:00 Registration Open
Wednesday, March 26, 2008
07:00:00 Registration Open
09:40:00 Grand Opening Refreshment Break in the Exhibit Hall
11:00:00 Chairperson’s Remarks Hing L Sham
11:10:00 Introductory Lecture: Strategies for Productive Medicinal Chemistry Terence A Kelly
11:40:00 Meeting the Challenges of Our Industry - The Role of Technology in a Winning R&D Strategy James B Summers
12:10:00 In Silico / Biological Fingerprinting: The Challenge of Experimental Data to Concepts of Structural and Activity Similarity and Risk Management Jonathan Mason
12:40:00 Technology Spotlight
13:10:00 Walk & Talk Luncheon in the Exhibit Hall CASE STUDIES IN PAIN
14:15:00 Chairperson’s Remarks Mark J Suto
14:20:00 Purinergic Receptor Antagonists: Novel Treatments for Inflammatory and Neuropathic Pain Michael P Dillon
14:50:00 Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonists for the Treatment of Migraine: Challenges in the Development of Clinical Candidate MK-0974 Christopher Steven Burgey
15:20:00 Discovery of TRPV1 Antagonists for Treatment of Pain Su Houng Lee
15:50:00 Potassium Channel Modulators for the Treatment of Pain Mark J Suto
16:20:00 Reception in the Exhibit Hall (Sponsorship Available)
17:00:00 Break-out Discussions in the Exhibit Hall
Thursday, March 27, 2008
08:25:00 Chairperson’s Remarks David H Price
08:30:00 Tykerb and Beyond Dirk A Heerding
09:15:00 CCR5 Antagonists for the Treatment of HIV;The Discovery of Maraviroc David H Price
10:00:00 Technology Spotlight (Sponsorship Available)
10:15:00 Technology Spotlight (Sponsorship Available)
10:30:00 Poster Competition & Refreshment Break in the Exhibit Hall CASE STUDIES IN ONCOLOGY CHEMISTRY
11:30:00 Histone Deacetylase Inhibitors: Bench to Bedside Thomas A. Miller
12:00:00 Sagopilone (ZK-EPO): From a Natural Product to a Fully Synthetic Clinical Development Candidate Ulrich Klar
12:30:00 Presentation I: AllChem: Idea Generator for Medicinal Chemists Richard D Cramer
13:00:00 Presentation II (Sponsorship Available)
13:30:00 Break
13:45:00 Chairperson’s Remarks Mark Ashwell
13:50:00 SAR in the Area of Antibody-Targeted Chemotherapy: Mylotarg and other Calicheamicin Conjugates Philip R Hamann
14:20:00 The Discovery and Early Development of ARQ 197, a Selective c-Met Inhibitor Mark Ashwell
14:50:00 Discovery and Development of Potent and Highly Selective c-Met/ HGFR Inhibitors Robert Kania
15:20:00 Plenary Keynote Speaker Ice Bound - A Doctor’s Incredible Battle for Survival at the South Pole Jerri Nielsen
16:00:00 Ice Cream Refreshment Break in the Exhibit Hall with BEST OF SHOW AWARDS
16:45:00 Steroid Sulfatase Inhibition: From Concept to Clinical Trial Lawrence Woo
17:15:00 Discovery of Benzodiazepinone Inhibitors of the p53:HDM2 Interaction Mark R Player
17:45:00 End of Session
Friday, March 28, 2008
08:30:00 Chairperson’s Remarks Christopher Burns
08:35:00 Discovery and Advancement of 4’-Substituted Nucleosides for the Treatment of Hepatitis C David B Smith
09:05:00 Beyond Boceprevir: Development of Second Generation HCV NS3 Protease Inhibitor Kevin Chen
09:35:00 Allosteric Non-Nucleoside Inhibitors of HCV RNA Polymerase (NS5B) Christopher Burns
10:05:00 Technology Spotlight (Sponsorship Available)
10:20:00 Coffee Break in the Foyer METABOLIC DISEASES
11:00:00 Agonists of GPR119 / GDIR Mediate Glycemic Control via Glucose Dependent Insulin and Incretin Release Robert L. Jones
11:30:00 The Discovery of Novel CB1 Receptor Antagonists Phill Cowley
12:00:00 Luncheon Workshop (Sponsorship Available) or Lunch on Your Own
13:00:00 Chairperson’s Remarks Aubrey Mendonca
13:05:00 Discovery of Novel DPP-4 Inhibitors Tesfaye Biftu
13:35:00 Discovery of Taranabant, a Novel CB1R Inverse Agonist for the Treatment of Obesity Linus S Lin
14:05:00 Fused Pyrimidine Heterocycles as Selective 5-HT2A Antagonists Brock T Shireman
14:35:00 Medicinal Chemistry Efforts Leading to the Optimization of Histamine H3 Receptor Antagonists Robert J Altenbach
15:05:00 Close of Conference
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.